Transforming growth factor beta engages TACE/ADAM17 and ErbB3 to activate PI3K/Akt in HER2-overexpressing breast cancer and desensitizes cells to trastuzumab

被引：0
|
作者：
Wang, E. [1 ]
Xiang, B. [1 ]
Olivares, M. G. [1 ]
Chang, C. [1 ]
Arteaga, C. L. [1 ]
机构：
[1] Vanderbilt Univ, Nashville, TN USA
来源：
CANCER RESEARCH | 2009年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：72S / 72S
页数：1
相关论文
共 50 条
  • [1] Transforming growth factor β engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab
    Wang, Shizhen Emily
    Xian, Bin
    Guix, Marta
    Olivares, Maria Graciela
    Parker, Joel
    Chung, Christine H.
    Pandiella, Atanasio
    Arteaga, Carlos L.
    MOLECULAR AND CELLULAR BIOLOGY, 2008, 28 (18) : 5605 - 5620
  • [2] Growth Suppression of HER2-Overexpressing Breast Cancer Cells by Berberine via Modulation of the HER2/PI3K/Akt Signaling Pathway
    Kuo, Han-Peng
    Chuang, Tzu-Chao
    Yeh, Ming-Han
    Hsu, Shih-Chung
    Way, Tzong-Der
    Chen, Po-Yuan
    Wang, Shan-Shue
    Chang, Yung-Hsien
    Kao, Ming-Ching
    Liu, Jah-Yao
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2011, 59 (15) : 8216 - 8224
  • [3] Calorie restriction reduces PI3K/Akt signaling and tumorigenic potential in HER2-overexpressing breast cancer
    Smith, Laura A.
    Rainey, Magdalena A.
    Sheth, Nishita T.
    O'Flanagan, Ciara H.
    Bowers, Laura W.
    Hursting, Stephen D.
    CANCER RESEARCH, 2018, 78 (13)
  • [4] Ganoderma tsugae Extract Inhibits Growth of HER2-Overexpressing Cancer Cells via Modulation of HER2/PI3K/Akt Signaling Pathway
    Kuo, Han-Peng
    Hsu, Shih-Chung
    Ou, Chien-Chih
    Li, Jhy-Wei
    Tseng, Hsiu-Hsueh
    Chuang, Tzu-Chao
    Liu, Jah-Yao
    Chen, Shih-Jung
    Su, Muh-Hwan
    Cheng, Yung-Chi
    Chou, Wei-Yuan
    Kao, Ming-Ching
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013
  • [5] hMENA11a contributes to HER3-mediated resistance to PI3K inhibitors in HER2-overexpressing breast cancer cells
    P Trono
    F Di Modugno
    R Circo
    S Spada
    A Di Benedetto
    R Melchionna
    B Palermo
    S Matteoni
    S Soddu
    M Mottolese
    R De Maria
    P Nisticò
    Oncogene, 2016, 35 : 887 - 896
  • [6] hMENA11a contributes to HER3-mediated resistance to PI3K inhibitors in HER2-overexpressing breast cancer cells
    Trono, P.
    Di Modugno, F.
    Circo, R.
    Spada, S.
    Di Benedetto, A.
    Melchionna, R.
    Palermo, B.
    Matteoni, S.
    Soddu, S.
    Mottolese, M.
    De Maria, R.
    Nistio, P.
    ONCOGENE, 2016, 35 (07) : 887 - 896
  • [7] PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer
    Serra, V.
    Scaltriti, M.
    Prudkin, L.
    Eichhorn, P. J. A.
    Ibrahim, Y. H.
    Chandarlapaty, S.
    Markman, B.
    Rodriguez, O.
    Guzman, M.
    Rodriguez, S.
    Gili, M.
    Russillo, M.
    Parra, J. L.
    Singh, S.
    Arribas, J.
    Rosen, N.
    Baselga, J.
    ONCOGENE, 2011, 30 (22) : 2547 - 2557
  • [8] PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer
    V Serra
    M Scaltriti
    L Prudkin
    P J A Eichhorn
    Y H Ibrahim
    S Chandarlapaty
    B Markman
    O Rodriguez
    M Guzman
    S Rodriguez
    M Gili
    M Russillo
    J L Parra
    S Singh
    J Arribas
    N Rosen
    J Baselga
    Oncogene, 2011, 30 : 2547 - 2557
  • [9] PI3K inhibitors in trastuzumab-resistant HER2-positive breast cancer cells with PI3K pathway alterations
    Chung, Wei-Pang
    Huang, Wei-Lun
    Lee, Chun-Hui
    Hsu, Hui-Ping
    Huang, Wan-Ling
    Liu, You-Yu
    Su, Wu-Chou
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (07): : 3067 - +
  • [10] Targeting of ErbB3 with functional cooperative miRNAs enhances efficacy of trastuzumab in ErbB2-overexpressing breast cancer cells
    Lyu, Hui
    Huang, Jingcao
    Wang, Bolun
    Han, Amy
    Liu, Bolin
    CANCER RESEARCH, 2018, 78 (13)
12345